g but higher target levels may be
necessary depending on the risk of orthostatic hypotension and
other side effects.
Low density lipoprotein target of < 1.8 mmol/L (< 70 mg/dL) and
reduced by at least 50% of baseline. If high intensity statin therapy
(with or without ezetimibe) is tolerated, target levels < 1.4 mmol/L (55
mg/dL) are